HBadMSCs
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HBadMSCs, covering 2025-09-29 to 2025-09-29. Get the full timeline:
Most recent: Clinical Trial Update: Individual Patient Expanded Access IND of Autologous HBadMSCs for the Treatment of Amyotrophic Lateral Sclerosis